Raised fasting plasma glucose a better predictor of diabetes than the IDF definition of the metabolic syndrome

Diabetes Research and Clinical Practice

Volumn 85, Issue 2, 2009, Pages

  Nakagami, Tomoko ^a   Tajima, Naoko ^b   Oizumi, Toshihide ^c   Karasawa, Shigeru ^c   Wada, Kiriko ^c   Kameda, Wataru ^c   Suga, Shinji ^c   Kato, Takeo ^c   Daimon, Makoto ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

Abdominal adiposity; Diabetes; Fasting plasma glucose; Incidence; Metabolic syndrome

Indexed keywords

GLUCOSE;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE CLASSIFICATION; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PATIENT IDENTIFICATION; PREDICTION; REFERENCE VALUE; RISK ASSESSMENT; SCREENING TEST; WAIST CIRCUMFERENCE;

ABDOMEN; ADIPOSE TISSUE; ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FOLLOW-UP STUDIES; HUMANS; JAPAN; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 67649836843     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.05.002     Document Type: Article

References (11)

1. Kohro T., Furui Y., Mitsutake N., Fujii R., Morita H., Oku S., et al. The Japanese national health screening and intervention aimed at preventing worsening of the metabolic syndrome. Int. Heart J. 49 (2008) 193-203
2. Daimon M., Oizumi T., Saitoh T., Kameda W., Hirata A., Yamaguchi H., et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care 26 (2003) 2015-2020
3. World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications, Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus, WHO, Geneva, 1999.
4. Alberti K.G.M., Zimmet P., Shaw J., and Grundy S.M. The IDF Consensus Worldwide Definition of the Metabolic Syndrome (2006), International Diabetes Federation, Brussels
5. Hara K., Matsushita Y., Horikoshi M., Yoshiike N., Yokoyama T., Tanaka H., et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care 29 (2006) 1123-1124
6. Miyawaki T., Hirata M., Moriyama K., Sasaki Y., Aono H., Saito N., et al. Metabolic syndrome in Japanese diagnosed with visceral fat measurement by computed tomography. Proceedings of the Japan Academy, Series V B 81 (2005) 471-479
7. Ford E.S., Li C., and Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 31 (2008) 1898-1904
8. Wang J.J., Li H.B., Kinnunen L., Hu G., Järvinen T.M., Miettinen M.E., et al. How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population?. Atherosclerosis 192 (2007) 161-168
9. Cheung B.M., Wat N.M., Man Y.B., Tam S., Thomas G.N., Leung G.M., et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care 30 (2007) 1430-1436
10. Cameron A.J., Magliano D.J., Zimmet P.Z., Welborn T.A., Colagiuri S., Tonkin A.M., et al. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J. Intern. Med. 264 (2008) 177-186
11. Lorenzo C., Williams K., Hunt K.J., and Haffner S.M. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30 (2007) 8-13